Showing results (2031-2040 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|April 13, 2005
Comparison of the pharmacokinetics of lansoprazole 15- and 30-mg sachets for suspension versus intact capsulesFouad Amer, Michael D Karol, Wei-Jian Pan, et al.
Clinical Therapeutics|April 13, 2005
Relative bioavailability and pharmacokinetics of a new sibutramine formulation in healthy male subjects: a randomized, open-label, two-period, comparative crossover studyJi-Young Park, Kyoung-Ah Kim, Pil-Whan Park, et al.
Clinical Therapeutics|April 13, 2005
Patterns of health care resource utilization after macrolide treatment failure: results from a large, population-based cohort with acute sinusitis, acute bronchitis, and community-acquired pneumoniaJasmanda H Wu, David H Howard, John E McGowan, et al.
Clinical Therapeutics|July 25, 2006
Long-acting risperidone: focus on safetyHans-Jürgen Möller
Clinical Therapeutics|July 25, 2006
Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteersMona Darwish, Mary Kirby, Philmore Robertson, et al.
Clinical Therapeutics|July 25, 2006
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on studyJoseph C Gathe, Robin Wood, Ian Sanne, et al.
Clinical Therapeutics|July 25, 2006
Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm studyJoseph Biederman, Eric Mick, Stephen V Faraone, et al.
Clinical Therapeutics|July 25, 2006
A double-blind, randomized trial to evaluate the pharmacokinetics and tolerability of 30 or 40 mg/d oral olanzapine relative to 20 mg/d oral olanzapine in stable psychiatric subjectsMalcolm Mitchell, Robert Riesenberg, Mohammad A Bari, et al.
Clinical Therapeutics|July 25, 2006
Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trialsJean P Rowan, James A Simon, Leon Speroff, et al.
Clinical Therapeutics|July 25, 2006
Second-generation antidepressant discontinuation and depressive relapse in adult patients with bipolar depression: results of a retrospective database analysisAlex Z Fu, Dale B Christensen, Richard A Hansen, et al.
Pageof 680